Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Zhaopeng Li, Deyong Bu, Xiaobin Wang, Lin Zhu, Daoyan Lei, Fengling Tang, Xianghua Sun, Cheng Chen, Xiang Ji & Song Bai. (2023) Chidamide and Oxaliplatin Synergistically Inhibit Colorectal Cancer Growth by Regulating the RPS27A-MDM2-P53 Axis. OncoTargets and Therapy 16, pages 703-721.
Read now
Read now
Katrina V. Good, Alexia Martínez de Paz, Monica Tyagi, Manjinder S. Cheema, Anita A. Thambirajah, Taylor L. Gretzinger, Gilda Stefanelli, Robert L. Chow, Oliver Krupke, Michael Hendzel, Kristal Missiaen, Alan Underhill, Nicoletta Landsberger & Juan Ausió. (2017) Trichostatin A decreases the levels of MeCP2 expression and phosphorylation and increases its chromatin binding affinity. Epigenetics 12:11, pages 934-944.
Read now
Read now
Ercan Cacan. (2017) Epigenetic regulation of RGS2 (Regulator of G-protein signaling 2) in chemoresistant ovarian cancer cells. Journal of Chemotherapy 29:3, pages 173-178.
Read now
Read now
Articles from other publishers (55)
Bin Wang, Youcai Liu, Lejing Zhang, Yajuan Wang, Zhaoxi Li & Xin Chen. (2023) Design, Synthesis, and Antiproliferative Activity of Selective Histone Deacetylases 6 Inhibitors Containing a Tetrahydropyridopyrimidine Scaffold. Molecules 28:21, pages 7323.
Crossref
Crossref
Max J. Carlsson & Jörg Fahrer. 2023. HDAC/HAT Function Assessment and Inhibitor Development. HDAC/HAT Function Assessment and Inhibitor Development
241
252
.
Yiyang Li, Wei Zhou, Xiangbing Meng, Sarina D. Murray, Long Li, Abby Fronk, Vanessa J. Lazaro-Camp, Kuo-kuang Wen, Meng Wu, Adam Dupuy, Kimberly K. Leslie & Shujie Yang. (2022) Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer. Cancers 14:19, pages 4883.
Crossref
Crossref
Lena Hess, Verena Moos, Arnel A. Lauber, Wolfgang Reiter, Michael Schuster, Natascha Hartl, Daniel Lackner, Thorina Boenke, Anna Koren, Paloma M. Guzzardo, Brigitte Gundacker, Anna Riegler, Petra Vician, Claudia Miccolo, Susanna Leiter, Mahesh B. Chandrasekharan, Terezia Vcelkova, Andrea Tanzer, Jun Qi Jun, James Bradner, Gerald Brosch, Markus Hartl, Christoph Bock, Tilmann Bürckstümmer, Stefan Kubicek, Susanna Chiocca, Srividya Bhaskara & Christian Seiser. (2022) A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation. PLOS Genetics 18:8, pages e1010376.
Crossref
Crossref
Zheng Jian, Yichao Han, Wentian Zhang, Chengqiang Li, Wei Guo, Xijia Feng, Bin Li & Hecheng Li. (2022) Anti-tumor effects of dual PI3K-HDAC inhibitor CUDC-907 on activation of ROS-IRE1α-JNK-mediated cytotoxic autophagy in esophageal cancer. Cell & Bioscience 12:1.
Crossref
Crossref
Kairui Yue, Mengting Qin, Chao Huang, C. James Chou, Yuqi Jiang & Xiaoyang Li. (2022) Comparison of three zinc binding groups for HDAC inhibitors – A potency, selectivity and enzymatic kinetics study. Bioorganic & Medicinal Chemistry Letters 70, pages 128797.
Crossref
Crossref
Simona Barone, Emilia Cassese, Antonella Ilenia Alfano, Margherita Brindisi & Vincenzo Summa. (2022) Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology. Journal of Medicinal Chemistry 65:4, pages 3080-3097.
Crossref
Crossref
Jie Peng, Shu‐Jun Li, Xiao Fu, Yi Liu & Xie‐Lan Zhao. (2020)
Chidamide acts on the histone deacetylase‐mediated
miR
‐34a/Bcl‐2 axis to regulate
NB4
cell line proliferation and apoptosis
. The Kaohsiung Journal of Medical Sciences 36:12, pages 1004-1013.
Crossref
Crossref
Wentian Zhang, Yajie Zhang, Tian Tu, Sabastian Schmull, Yu Han, Wenbo Wang & Hecheng Li. (2020) Dual inhibition of HDAC and tyrosine kinase signaling pathways with CUDC-907 attenuates TGFβ1 induced lung and tumor fibrosis. Cell Death & Disease 11:9.
Crossref
Crossref
Xiaolong Tang, Guo Li, Fengting Su, Yanlin Cai, Lei Shi, Yuan Meng, Zuojun Liu, Jie Sun, Ming Wang, Minxian Qian, Zimei Wang, Xingzhi Xu, Yong-Xian Cheng, Wei-Guo Zhu & Baohua Liu. (2020) HDAC8 cooperates with SMAD3/4 complex to suppress SIRT7 and promote cell survival and migration. Nucleic Acids Research 48:6, pages 2912-2923.
Crossref
Crossref
Yuhong Fu, Ying Wang, Xinyuan Gao, Huiyao Li & Yue Yuan. (2020) Dynamic Expression of HDAC3 in db/db Mouse RGCs and Its Relationship with Apoptosis and Autophagy. Journal of Diabetes Research 2020, pages 1-8.
Crossref
Crossref
Duraid H. Al-Amily & Mohammed Hassan Mohammed. (2019) Design, Synthesis, and Docking Study of Acyl Thiourea Derivatives as Possible Histone Deacetylase Inhibitors with a Novel Zinc Binding Group. Scientia Pharmaceutica 87:4, pages 28.
Crossref
Crossref
Martijn R. H. Zwinderman, Sander de Weerd & Frank J. Dekker. (2019) Targeting HDAC Complexes in Asthma and COPD. Epigenomes 3:3, pages 19.
Crossref
Crossref
Jennifer Hern�ndez-Ju�rez, Orlando Vargas-Sierra, Luis Herrera, David Cant� De Le�n, Jorge Fern�ndez-Retana, Carlos P�rez-Plasencia, C�sar L�pez-Camarillo, Patricio Gariglio & Jos� D�az-Ch�vez. (2019) Sodium-coupled monocarboxylate transporter is a target of epigenetic repression in cervical cancer. International Journal of Oncology.
Crossref
Crossref
Panpan An, Jiexin Li, Linlin Lu, Yingmin Wu, Yuyi Ling, Jun Du, Zhuojia Chen & Hongsheng Wang. (2019) Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals. European Journal of Pharmacology 845, pages 16-23.
Crossref
Crossref
A. Umamaheswari, A. Puratchikody & Sakthivel Balasubramaniyan. 2019. Computer Applications in Drug Discovery and Development. Computer Applications in Drug Discovery and Development
140
172
.
Seema Saksena & Pradeep K. Dudeja. (2019) Role of Membrane Transporters in Intestinal Cancers. Cellular and Molecular Gastroenterology and Hepatology 7:1, pages 241-242.
Crossref
Crossref
Ankita Saha, Sarika Tiwari, Subramanian Dharmarajan, Deborah C. Otteson & Teri L. Belecky-Adams. (2018) Class I histone deacetylases in retinal progenitors and differentiating ganglion cells. Gene Expression Patterns 30, pages 37-48.
Crossref
Crossref
Soon-Duck Ha, Ori Solomon, Masoud Akbari, Alp Sener & Sung Ouk Kim. (2018) Histone deacetylase 8 protects human proximal tubular epithelial cells from hypoxia-mimetic cobalt- and hypoxia/reoxygenation-induced mitochondrial fission and cytotoxicity. Scientific Reports 8:1.
Crossref
Crossref
Sanzida Jahan, Jian‐Min Sun, Shihua He & James R. Davie. (2017) Transcription‐dependent association of HDAC2 with active chromatin. Journal of Cellular Physiology 233:2, pages 1650-1657.
Crossref
Crossref
Sahar Bayat, Mahmoud Shekari Khaniani, Jalal Choupani, Mohammad Reza Alivand & Sima Mansoori Derakhshan. (2018) HDACis (class I), cancer stem cell, and phytochemicals: Cancer therapy and prevention implications. Biomedicine & Pharmacotherapy 97, pages 1445-1453.
Crossref
Crossref
Soon-Duck Ha, Woohyun Cho & Sung Kim. (2017) HDAC8 Prevents Anthrax Lethal Toxin-induced Cell Cycle Arrest through Silencing PTEN in Human Monocytic THP-1 Cells. Toxins 9:5, pages 162.
Crossref
Crossref
Mohamed D. M. Traoré, Vincent Zwick, Claudia A. Simões-Pires, Alessandra Nurisso, Mark Issa, Muriel Cuendet, Marjorie Maynadier, Sharon Wein, Henri Vial, Helene Jamet & Yung-Sing Wong. (2017) Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6. ACS Omega 2:4, pages 1550-1562.
Crossref
Crossref
Ercan Cacan. (2017) Epigenetic-mediated immune suppression of positive co-stimulatory molecules in chemoresistant ovarian cancer cells. Cell Biology International 41:3, pages 328-339.
Crossref
Crossref
Mee-Young Ahn & Jung-Hoon Yoon. (2017) Histone deacetylase 8 as a novel therapeutic target in oral squamous cell carcinoma. Oncology Reports 37:1, pages 540-546.
Crossref
Crossref
Zhihui Liu & Carol J. Thiele. 2017. Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors. Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors
83
125
.
Elizabeth I. Spehalski, Philip J. Tofilon & Kevin Camphausen. 2017. Increasing the Therapeutic Ratio of Radiotherapy. Increasing the Therapeutic Ratio of Radiotherapy
57
78
.
Yan Long, Wen-Bin Tsai, Jeffrey T. Chang, Marcos Estecio, Medhi Wangpaichitr, Naramol Savaraj, Lynn G. Feun, Helen H.W. Chen & Macus Tien Kuo. (2016)
Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of
ASS1
promoter DNA methylation
. Oncotarget 7:50, pages 82658-82670.
Crossref
Crossref
Roberto Luksch, Maria Rita Castellani, Paola Collini, Bruno De Bernardi, Massimo Conte, Claudio Gambini, Lorenza Gandola, Alberto Garaventa, Davide Biasoni, Marta Podda, Angela Rita Sementa, Gemma Gatta & Gian Paolo Tonini. (2016) Neuroblastoma (Peripheral neuroblastic tumours). Critical Reviews in Oncology/Hematology 107, pages 163-181.
Crossref
Crossref
Yangzom D. BhutiaEllappan BabuSabarish RamachandranShengping YangMuthusamy ThangarajuVadivel Ganapathy. (2016) SLC transporters as a novel class of tumour suppressors: identity, function and molecular mechanisms. Biochemical Journal 473:9, pages 1113-1124.
Crossref
Crossref
Lihui Wang, Xuefei Bao, Jingyu Yang, Huahuan Li, Qifan Zhou, Xiaorui Jiang, Meng Li, Xing Liu, Xiangzhong Yuan, Yuhong Sun, Junli Chen, Jingyuan Zhang, Guoliang Chen & Chunfu Wu. (2016) Novel cinnamohydroxamic acid derivatives as HDAC inhibitors with anticancer activity in vitro and in vivo. Chemico-Biological Interactions 249, pages 64-70.
Crossref
Crossref
Samantha G. PattendenJeremy M. SimonAminah WaliChatura N. JayakodyJacob TroutmanAndrew W. McFaddenJoshua WootenCameron C. WoodStephen V. FryeWilliam P. JanzenIan J. Davis. (2016) High-throughput small molecule screen identifies inhibitors of aberrant chromatin accessibility. Proceedings of the National Academy of Sciences 113:11, pages 3018-3023.
Crossref
Crossref
Xianping Lu, Zhiqiang Ning, Zhibin Li, Haixiang Cao & Xinhao Wang. (2016) Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in China. Intractable & Rare Diseases Research 5:3, pages 185-191.
Crossref
Crossref
Genevieve P. Delcuve, Dilshad H. Khan, Vichithra R. B. Liyanage, Sanzida Jahan, Mojgan Rastegar, Lorrie A. Kirshenbaum & James R. Davie. 2016. Epigenetics in Cardiac Disease. Epigenetics in Cardiac Disease
1
35
.
Seok-Mo Kim, Ki-Cheong Park, Jeong-Yong Jeon, Bup-Woo Kim, Hyeung-Kyoo Kim, Ho-Jin Chang, Seung-Hoon Choi, Cheong-Soo Park & Hang-Seok Chang. (2015) Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer. BMC Cancer 15:1.
Crossref
Crossref
Yuan Tian, Vincent W.S. Wong, Grace L.H. Wong, Weiqin Yang, Hanyong Sun, Jiayun Shen, Joanna H.M. Tong, Minnie Y.Y. Go, Yue S. Cheung, Paul B.S. Lai, Mingyan Zhou, Gang Xu, Tim H.M. Huang, Jun Yu, Ka F. To, Alfred S.L. Cheng & Henry L.Y. Chan. (2015) Histone Deacetylase HDAC8 Promotes Insulin Resistance and β-Catenin Activation in NAFLD-Associated Hepatocellular Carcinoma. Cancer Research 75:22, pages 4803-4816.
Crossref
Crossref
Chongxi Fan, Yunhu Pan, Yang Yang, Shouyin Di, Shuai Jiang, Zhiqiang Ma, Tian Li, Zhipei Zhang, Weimiao Li, Xiaofei Li, Russel J. Reiter & Xiaolong Yan. (2015)
Retracted:
HDAC
1 inhibition by melatonin leads to suppression of lung adenocarcinoma cells via induction of oxidative stress and activation of apoptotic pathways
. Journal of Pineal Research 59:3, pages 321-333.
Crossref
Crossref
Song Zhang, Weibin Huang, Xiaonan Li, Zhicheng Yang & Binghong Feng. (2015) Synthesis, Biological Evaluation, and Computer-Aided Drug Designing of New Derivatives of Hyperactive Suberoylanilide Hydroxamic Acid Histone Deacetylase Inhibitors. Chemical Biology & Drug Design 86:4, pages 795-804.
Crossref
Crossref
LELE LIN, HONGPENG JIANG, MINGKUI HUANG, XU HOU, XUEPU SUN, XIAN JIANG, XUESONG DONG, XUEYING SUN, BAOGUO ZHOU & HAIQUAN QIAO. (2015) Depletion of histone deacetylase 1 inhibits metastatic abilities of gastric cancer cells by regulating the miR-34a/CD44 pathway. Oncology Reports 34:2, pages 663-672.
Crossref
Crossref
N C Hait, D Avni, A Yamada, M Nagahashi, T Aoyagi, H Aoki, C I Dumur, Z Zelenko, E J Gallagher, D Leroith, S Milstien, K Takabe & S Spiegel. (2015) The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer. Oncogenesis 4:6, pages e156-e156.
Crossref
Crossref
Anil Rana, Jimi Marin Alex, Monika Chauhan, Gaurav Joshi & Raj Kumar. (2014) A review on pharmacophoric designs of antiproliferative agents. Medicinal Chemistry Research 24:3, pages 903-920.
Crossref
Crossref
Shawal Spencer, Agustina Gugliotta, Jennifer Koenitzer, Hansjörg Hauser & Dagmar Wirth. (2015) Stability of single copy transgene expression in CHOK1 cells is affected by histone modifications but not by DNA methylation. Journal of Biotechnology 195, pages 15-29.
Crossref
Crossref
Hai-Ying Li, Hai-Ge Ye, Chi-Qi Chen, Li-Hui Yin, Jian-Bo Wu, Li-Cai He & Shen-Meng Gao. (2015) Honokiol Induces Cell Cycle Arrest and Apoptosis Via Inhibiting Class I Histone Deacetylases in Acute Myeloid Leukemia. Journal of Cellular Biochemistry 116:2, pages 287-298.
Crossref
Crossref
Philipp Anstaett & Gilles Gasser. 2014. Bioorganometallic Chemistry. Bioorganometallic Chemistry
1
42
.
Sijana H. Dzinic, Kang Chen, Archana Thakur, Alexander Kaplun, R. Daniel Bonfil, Xiaohua Li, Jason Liu, M. Margarida Bernardo, Allen Saliganan, Jessica B. Back, Hiroshi Yano, Dana L. Schalk, Elyse N. Tomaszewski, Ahmed S. Beydoun, Gregory Dyson, Adelina Mujagic, David Krass, Ivory Dean, Qing-Sheng Mi, Elisabeth Heath, Wael Sakr, Lawrence G. Lum & Shijie Sheng. (2014) Maspin expression in prostate tumor elicits host anti-tumor immunity. Oncotarget 5:22, pages 11225-11236.
Crossref
Crossref
Y Kang, H Nian, P Rajendran, E Kim, W M Dashwood, J T Pinto, L A Boardman, S N Thibodeau, P J Limburg, C V Löhr, W H Bisson, D E Williams, E Ho & R H Dashwood. (2014) HDAC8 and STAT3 repress BMF gene activity in colon cancer cells. Cell Death & Disease 5:10, pages e1476-e1476.
Crossref
Crossref
Yun-Han Lee, Daekwan Seo, Kyung-Ju Choi, Jesper B. Andersen, Min-Ah Won, Mitsuteru Kitade, Luis E. Gómez-Quiroz, Adam D. Judge, Jens U. Marquardt, Chiara Raggi, Elizabeth A. Conner, Ian MacLachlan, Valentina M. Factor & Snorri S. Thorgeirsson. (2014) Antitumor Effects in Hepatocarcinoma of Isoform-Selective Inhibition of HDAC2. Cancer Research 74:17, pages 4752-4761.
Crossref
Crossref
Dineo Khabele. (2014) The Therapeutic Potential of Class I Selective Histone Deacetylase Inhibitors in Ovarian Cancer. Frontiers in Oncology 4.
Crossref
Crossref
Yurie Fukui, Koichi Narita, Singo Dan, Takao Yamori, Akihiro Ito, Minoru Yoshida & Tadashi Katoh. (2014) Total synthesis of burkholdacs A and B and 5,6,20-tri-epi-burkholdac A: HDAC inhibition and antiproliferative activity. European Journal of Medicinal Chemistry 76, pages 301-313.
Crossref
Crossref
Florian Thaler & Ciro Mercurio. (2014) Towards Selective Inhibition of Histone Deacetylase Isoforms: What Has Been Achieved, Where We Are and What Will Be Next. ChemMedChem 9:3, pages 523-536.
Crossref
Crossref
Alison C. West & Ricky W. Johnstone. (2014) New and emerging HDAC inhibitors for cancer treatment. Journal of Clinical Investigation 124:1, pages 30-39.
Crossref
Crossref
Sijana H. Dzinic, Alexander Kaplun, Xiaohua Li, Margarida Bernardo, Yonghong Meng, Ivory Dean, David Krass, Paul Stemmer, Namhee Shin, Fulvio Lonardo & Shijie Sheng. (2013) Identification of an Intrinsic Determinant Critical for Maspin Subcellular Localization and Function. PLoS ONE 8:11, pages e74502.
Crossref
Crossref
Muhammad FarooqMohammad AM Wadaan. (2013) Epigenetic targets in hepatocellular carcinoma cells: identification of chaperone protein complexes with histone deacetylases. Epigenomics 5:5, pages 501-512.
Crossref
Crossref
Jiro Kikuchi, Satoshi Yamada, Daisuke Koyama, Taeko Wada, Masaharu Nobuyoshi, Tohru Izumi, Miyuki Akutsu, Yasuhiko Kano & Yusuke Furukawa. (2013) The Novel Orally Active Proteasome Inhibitor K-7174 Exerts Anti-myeloma Activity in Vitro and in Vivo by Down-regulating the Expression of Class I Histone Deacetylases. Journal of Biological Chemistry 288:35, pages 25593-25602.
Crossref
Crossref
Muhammad Farooq, Wael N. Hozzein, Elsayed A. Elsayed, Nael A. Taha & Mohammad A.M. Wadaan. (2013) Identification of Histone Deacetylase 1 Protein Complexes in Liver Cancer Cells. Asian Pacific Journal of Cancer Prevention 14:2, pages 915-921.
Crossref
Crossref